Showing results (31-40 of 164) with videos related to
Sort By:
Pageof 17
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|September 28, 2022
A Delphi consensus panel about clinical management of early-stage EGFR-mutated non-small cell lung cancer (NSCLC) in Spain: a Delphi consensus panel studyDolores Isla, Enriqueta Felip, Pilar Garrido, et al.Journal of Comparative Effectiveness Research|September 30, 2017
Should clinically meaningful outcomes in cancer be based on individual survival rather than median overall survival?José A Sacristán, Tatiana Dilla, Pilar Garrido, et al.Cirugia Espanola|February 1, 2007
[Small flexible drains after cardiac surgery. Efficacy and safety of a new system]M Ibrahim Nassar, Rafael Martínez, Ramiro Llana, et al.Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|May 21, 2011
Management of lung cancer-associated anaemia: the Spanish Lung Cancer Anaemia Survey (SLCAS)Pere Gascón, José Almenárez, Ángel Artal, et al.Patient Preference and Adherence|January 1, 2016
Do new cancer drugs offer good value for money? The perspectives of oncologists, health care policy makers, patients, and the general populationTatiana Dilla, Luís Lizan, Silvia Paz, et al.Cancer|April 25, 2003
Gemcitabine and carboplatin in advanced transitional cell carcinoma of the urinary tract: an alternative therapyMiquel Nogué-Aliguer, Joan Carles, Antonio Arrivi, et al.Translational Lung Cancer Research|August 25, 2021
Acute anti-Ma2 paraneoplastic encephalitis associated to pembrolizumab: a case report and review of literatureVíctor Albarrán, Javier Pozas, Fernando Rodríguez, et al.Advances in Therapy|October 9, 2016
Perceptions of Oncologists, Healthcare Policy Makers, Patients and the General Population on the Value of Pharmaceutical Treatments in OncologyJosé A Sacristán, Luís Lizan, Marta Comellas, et al.JCO Precision Oncology|January 25, 2024
Characteristics and Survival Outcomes of Patients With Metastatic RET Fusion-Positive Solid Tumors Receiving Non-RET Inhibitor Standards of Care in a Real-World SettingAllan Hackshaw, Otto Fajardo, Urania Dafni, et al.Plos One|February 15, 2022
Suicide gene therapy by canine mesenchymal stem cell transduced with thymidine kinase in a u-87 glioblastoma murine model: Secretory profile and antitumor activityAntonio J Villatoro, Cristina Alcoholado, María Del Carmen Martín-Astorga, et al.Pageof 17